日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

三氟尿苷/替吡嘧啶联合或不联合贝伐珠单抗加XB2001（抗IL-1α抗体）的安全性和有效性：一项单中心1期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:40.8
doi:10.1038/s41392-024-02116-4
Marion Thibaudin ，Nicolas Roussot ，Chloé Burlot ，Antonin Schmitt ，Julie Vincent ，Zoé Tharin ，Leila Bengrine ，Hélène Bellio ，Aurélie Bertaut ，Léa Hampe ，Susy Daumoine ，Emilie Rederstorff ，Morgane Peroz ，Titouan Huppe ，Valentin Derangère ，David Rageot ，John Simard ，Caroline Truntzer ，Jean David Fumet ，Francois Ghiringhelli
IL-1α
发表日期：2025
文献求助 收藏

Corrigendum to "Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer": [ESMO Open 3 (2018) e000375]

对“评估度伐利尤单抗（MEDI4736）（抗PD-L1）联合tremelimumab（抗CTLA-4）与FOLFOX方案治疗转移性结直肠癌患者的安全性、耐受性和免疫活性的Ib/II期试验”的更正：[ESMO Open 3 (2018) e000375]

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101185
Fumet, Jean-David; Isambert, Nicolas; Hervieu, Alice; Zanetta, Sylvie; Guion, Jean-Florian; Hennequin, Audrey; Rederstorff, Emilie; Bertaut, Aurélie; Ghiringhelli, Francois
SMO
肿瘤
肠癌
肿瘤免疫
PD-L1
免疫/内分泌
发表日期：2023
文献求助 收藏

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

一项针对转移性多器官癌症患者的I期研究，评估阿特珠单抗、替拉戈鲁单抗和立体定向放射治疗联合疗法的疗效。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11534-6
Roussot, Nicolas; Fumet, Jean-David; Limagne, Emeric; Thibaudin, Marion; Hervieu, Alice; Hennequin, Audrey; Zanetta, Sylvie; Dalens, Lorraine; Fourrier, Théo; Galland, Loick; Jacob, Pierre; Bertaut, Aurélie; Rederstorff, Emilie; Chevalier, Cédric; Ghirardi, Sarah; Gilbert, Elodie; Khoukaz, Azzat; Martin, Etienne; Nicolet, Constance; Quivrin, Magali; Thibouw, David; Vulquin, Noémie; Truc, Gilles; Rouffiac, Magali; Ghiringhelli, Francois; Mirjolet, Céline
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma

基于血液的RNA特征在转移性胰腺腺癌吉西他滨治疗中的应用性能

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-22-946
Piquemal, David; Bruno, Roman; Bournet, Barbara; Ghiringhelli, Francois; Noguier, Florian; Canivet, Cindy; Bertaut, Aurélie; Pierrat, Fabien; Evesque, Ludovic; Gamez, Amelia; Cros, Jerome; Rederstorff, Emilie; Petit, Erwan; Adnet, Johan; Saint, Angélique; Drouillard, Antoine; Kempf, Emmanuelle; Soularue, Emilie; Vincent, Julie; Baumgaertner, Isabelle; Hennequin, Audrey; Tournigand, Christophe; Lopez Trabada Ataz, Daniel; Bengrine, Leila; Lepage, Come; Manfredi, Sylvain; Afchain, Pauline; Trouilloud, Isabelle; Gagnaire, Alice; LoConte, Noelle K; Bachet, Jean-Baptiste
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

The interaction between RPAP3 and TRBP reveals a possible involvement of the HSP90/R2TP chaperone complex in the regulation of miRNA activity

RPAP3 和 TRBP 之间的相互作用表明 HSP90/R2TP 分子伴侣复合物可能参与 miRNA 活性的调节

期刊:Nucleic Acids Research
影响因子:16.6
doi:10.1093/nar/gkac086
Yoann Abel, Christophe Charron, Camille Virciglio, Valérie Bourguignon-Igel, Marc Quinternet, Marie-Eve Chagot, Marie-Cécile Robert, Céline Verheggen, Christiane Branlant, Edouard Bertrand, Xavier Manival, Bruno Charpentier, Mathieu Rederstorff
信号转导
发表日期：2022
文献求助 收藏

Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study

在第一波和第二波新冠疫情期间，一家三级癌症中心的癌症患者和医护人员中SARS-CoV-2抗体血清阳性率的平行演变和差异：canSEROcov-II横断面研究

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2022.01.005
Ladoire, Sylvain; Rederstorff, Emilie; Goussot, Vincent; Parnalland, Sophie; Briot, Nathalie; Ballot, Elise; Truntzer, Caroline; Ayati, Siavoshe; Bengrine-Lefevre, Leila; Bremaud, Nathalie; Coudert, Bruno; Desmoulins, Isabelle; Favier, Laure; Fraisse, Cléa; Fumet, Jean-David; Hennequin, Audrey; Hervieu, Alice; Ilie, Silvia; Kaderbhai, Courèche; Lagrange, Aurélie; Martin, Nils; Mazilu, Irina; Mayeur, Didier; Palmier, Rémi; Simonet-Lamm, Anne-Laure; Vincent, Julie; Zanetta, Sylvie; Arnould, Laurent; Coutant, Charles; Bertaut, Aurélie; Ghiringhelli, François
SARS-CoV-2
新冠
肿瘤
肿瘤免疫
微生物学
发表日期：2022
文献求助 收藏

Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer

鉴定催产素相关长链非编码RNA并评估其在乳腺癌中的表达

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-86097-2
Behtaji, Sepehr; Ghafouri-Fard, Soudeh; Sayad, Arezou; Sattari, Ali; Rederstorff, Mathieu; Taheri, Mohammad
乳腺癌
肿瘤免疫
肿瘤
发表日期：2021
文献求助 收藏

Synergistic defects in pre-rRNA processing from mutations in the U3-specific protein Rrp9 and U3 snoRNA

U3 特异性蛋白 Rrp9 和 U3 snoRNA 突变导致前 rRNA 加工中的协同缺陷

期刊:Nucleic Acids Research
影响因子:16.6
doi:10.1093/nar/gkaa066
Guillaume Clerget, Valérie Bourguignon-Igel, Nathalie Marmier-Gourrier, Nicolas Rolland, Ludivine Wacheul, Xavier Manival, Christophe Charron, Joanna Kufel, Agnès Méreau, Véronique Senty-Ségault, David Tollervey, Denis L J Lafontaine, Christiane Branlant, Mathieu Rederstorff
发表日期：2020
文献求助 收藏

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment

一项精准医学 II 期研究评估了度伐利尤单抗和曲美利木单抗联合奥拉帕尼治疗对携带同源重组修复基因突变的实体瘤患者（奥拉帕尼治疗后有反应或病情稳定）的双重免疫疗法的疗效。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07253-x
Fumet, Jean-David; Limagne, Emeric; Thibaudin, Marion; Truntzer, Caroline; Bertaut, Aurélie; Rederstorff, Emilie; Ghiringhelli, Francois
免疫/内分泌
发表日期：2020
文献求助 收藏

Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer

一项Ib/II期临床试验，旨在评估度伐利尤单抗（MEDI4736）（抗PD-L1）联合曲美利木单抗（抗CTLA-4）与FOLFOX方案治疗转移性结直肠癌患者的安全性、耐受性和免疫活性。

期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2018-000375
Fumet, Jean-David; Isambert, Nicolas; Hervieu, Alice; Zanetta, Sylvie; Guion, Jean-Florian; Hennequin, Audrey; Rederstorff, Emilie; Bertaut, Aurélie; Ghiringhelli, Francois
肿瘤
肠癌
肿瘤免疫
PD-L1
免疫/内分泌
发表日期：2018
文献求助 收藏